Larix A/S   Report issue

For profit Phase 2 Phase 3
Founded: Herlev Denmark (2001)

Organization Overview

First Clinical Trial
2014
NCT02280447
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Larix A/S